PL1732556T3 - Sposób wytwarzania 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu oraz jego soli i hydratów - Google Patents

Sposób wytwarzania 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu oraz jego soli i hydratów

Info

Publication number
PL1732556T3
PL1732556T3 PL05717126T PL05717126T PL1732556T3 PL 1732556 T3 PL1732556 T3 PL 1732556T3 PL 05717126 T PL05717126 T PL 05717126T PL 05717126 T PL05717126 T PL 05717126T PL 1732556 T3 PL1732556 T3 PL 1732556T3
Authority
PL
Poland
Prior art keywords
benzopyran
piperazinyl
hydrates
salts
amino
Prior art date
Application number
PL05717126T
Other languages
English (en)
Inventor
Cornelis Bakker
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of PL1732556T3 publication Critical patent/PL1732556T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
PL05717126T 2004-03-25 2005-03-23 Sposób wytwarzania 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu oraz jego soli i hydratów PL1732556T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55595804P 2004-03-25 2004-03-25
EP04101228 2004-03-25
EP05717126A EP1732556B1 (en) 2004-03-25 2005-03-23 Process for the preparation of 3-amino-8-(1-piperazinyl)-2h-1-benzopyran-2-one and salts and hydrates thereof
PCT/EP2005/051326 WO2005092338A1 (en) 2004-03-25 2005-03-23 Process for the preparation of 3-amino-8-(1-piperazinyl) -2h-1-benzopyran-2-one and salts and hydrates thereof

Publications (1)

Publication Number Publication Date
PL1732556T3 true PL1732556T3 (pl) 2008-09-30

Family

ID=34928926

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05717126T PL1732556T3 (pl) 2004-03-25 2005-03-23 Sposób wytwarzania 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu oraz jego soli i hydratów

Country Status (12)

Country Link
US (2) US7776860B2 (pl)
EP (1) EP1732556B1 (pl)
JP (1) JP2007530507A (pl)
AR (1) AR049478A1 (pl)
AT (1) ATE388709T1 (pl)
CA (1) CA2554041A1 (pl)
DE (1) DE602005005308T2 (pl)
ES (1) ES2303674T3 (pl)
PL (1) PL1732556T3 (pl)
SA (1) SA05260061B1 (pl)
TW (1) TWI340136B (pl)
WO (1) WO2005092338A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR048112A1 (es) * 2004-03-25 2006-03-29 Solvay Pharm Bv Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
JP6061373B2 (ja) * 2012-07-24 2017-01-18 国立研究開発法人産業技術総合研究所 ２−ヒドロキシベンズアルデヒド化合物、これを含有するコラーゲン細胞外分泌阻害剤及び医薬品組成物
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586794T2 (de) 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
DK611489A (da) 1988-12-08 1990-06-09 Duphar Int Res Anxiolytisk aktive piperazinderivater og farmaceutiske praeparater med indhold af saadanne forbindelser
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
FR2670491B1 (fr) * 1990-12-14 1993-02-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
ATE204262T1 (de) 1991-09-18 2001-09-15 Glaxo Group Ltd Benzanilidderivate als 5-ht1d-antagonisten
AU3241093A (en) 1992-01-07 1993-08-03 Merrell Dow Pharmaceuticals Inc. Treatment of involuntary movements with 5HT-1A receptor agonists
EP0650964A1 (en) * 1993-11-02 1995-05-03 Duphar International Research B.V 1 2H-1-benzopyran-2-one-8-yl -piperazine derivatives
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
NL9401572A (nl) 1994-09-27 1996-05-01 Avebe Coop Verkoop Prod Zetmeelprodukten als tabletteerhulpstof, werkwijze voor het bereiden daarvan alsmede werkwijze voor het maken van tabletten.
PL189256B1 (pl) 1996-03-29 2005-07-29 Duphar Int Res Związki piperazyny i piperydyny, sposób ich wytwarzania, kompozycja farmaceutyczna zawierająca te związki, zastosowanie tych związków do wytwarzania leków
GB9706089D0 (en) 1997-03-24 1997-05-14 Scherer Ltd R P Pharmaceutical composition
PA8469101A1 (es) 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
US6376494B1 (en) * 1998-06-15 2002-04-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
US6312717B1 (en) * 1998-07-07 2001-11-06 Bristol-Myers Squibb Company Method for treatment of anxiety and depression
UA62015C2 (en) 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
GB0008563D0 (en) * 2000-04-07 2000-05-24 Cambridge Discovery Chemistry Investigating different physical and/or chemical forms of materials
JP2004231514A (ja) 2000-08-31 2004-08-19 Meiji Seika Kaisha Ltd ５−ｈｔ７受容体結合能を有し、かつ代謝的に安定なテトラヒドロベンズインドール誘導体
US20030008880A1 (en) * 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
US6696496B2 (en) * 2002-03-28 2004-02-24 Synthon Bv Low water-soluble venlafaxine salts
FR2837822B1 (fr) * 2002-03-29 2004-06-04 Bioprojet Soc Civ Formes polymorphes du fasidotril, leurs procedes de preparation et compositions pharmaceutiques les contenant
AR048112A1 (es) * 2004-03-25 2006-03-29 Solvay Pharm Bv Derivados de 1-(2h-1-benzopiran-2-on-8-il)-piperazina para el tratamiento de dolor
US20050215551A1 (en) * 2004-03-25 2005-09-29 Solvay Pharmaceuticals B.V. 1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders

Also Published As

Publication number Publication date
EP1732556A1 (en) 2006-12-20
ES2303674T3 (es) 2008-08-16
CA2554041A1 (en) 2005-10-06
AR049478A1 (es) 2006-08-09
TWI340136B (en) 2011-04-11
DE602005005308D1 (de) 2008-04-24
US7776860B2 (en) 2010-08-17
TW200611900A (en) 2006-04-16
US20110003830A1 (en) 2011-01-06
JP2007530507A (ja) 2007-11-01
US8173660B2 (en) 2012-05-08
DE602005005308T2 (de) 2009-10-08
EP1732556B1 (en) 2008-03-12
WO2005092338A1 (en) 2005-10-06
ATE388709T1 (de) 2008-03-15
US20050215566A1 (en) 2005-09-29
SA05260061B1 (ar) 2009-01-19

Similar Documents

Publication Publication Date Title
IL192241A (en) A process for making 4 - (benzimidazolylmethylamino) - benzamides and their salts
ZA200803527B (en) Crystals of laquinimod sodium, and process for the manufacture thereof
SI1797037T1 (sl) Postopek priprave 4-(4-((((4-kloro-3-(trifluorometil)fenil)amino)karbonil)amino) fenioksi)N-metilpiridin-2-karboksamida
IL234893A (en) A process for making derivatives of piperazine and diazepanyl benzamide
IL198847A (en) Process for making 2-imino-thiazolidine-4-on and several such histories
ZA200710173B (en) Tygecycline and methods of preparing 9-nitrominocycline
PL1844036T3 (pl) Sposób otrzymywania arypiprazolu
EP2038282A4 (en) SALTS OF PYRROLOPYRIMIDINONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
GB2442160B (en) Preparation of escitalopram free base and salts
PT1618111E (pt) Sais de clopidogrel e processo de preparação
EP1934140A4 (en) SILICA NANOBOITIERS AND METHODS OF ELEMENTS AND USES THEREOF
EP1946007A4 (en) ANDROSTERONE DERIVATIVES AND METHODS OF USE
ZA200701016B (en) Process for the preparation of isothiazole derivatives
PL1753720T3 (pl) Proces wytwarzania peryndoprylu i jego soli
HK1090377A1 (en) Process for the preparation of tubulin inhibitors
EP2069307A4 (en) PROCESS FOR THE PREPARATION OF MONTELUKAST AND ITS SALTS
IL178539A0 (en) Process for preparation of probucol derivatives
PL1732556T3 (pl) Sposób wytwarzania 3-amino-8-(1-piperazynylo)-2H-1-benzopiran-2-onu oraz jego soli i hydratów
ZA200804732B (en) Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
HU0401379D0 (en) Process for the preparation of risperidon
GB2398574B8 (en) Model for the development of vaccines
SI1732916T1 (sl) Postopek za pripravo alkoksikarbonilmetoksi-ciklopentanov